ABSTRACT: Targeting a newly-identified RNA polymerase II-associated PHF5A-PHF14-KMT2A transcriptional subcomplex with a KMT2A-WDR5 inhibitor impairs the self-renewal, pluripotency and in vivo tumorigenicity of pancreatic cancer stem cells
PROVIDER: PRJNA887833 | ENA |
REPOSITORIES: ENA
ACCESS DATA